3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Conditions
Prostatic Neoplasms
11
Lung Neoplasms
7
Colonic Neoplasms
5
Pancreatic Neoplasms
3
Pain, Postoperative
3
Inflammatory Bowel Diseases
3
Diverticulitis
3
Carcinoma, Hepatocellular
3
Urinary Bladder Neoplasms
2
Male Urogenital Diseases
2
Leiomyoma
2
Inflammation
2
Carcinoma, Non-Small-Cell Lung
2
Agnosia
2
Abdominal Cancer
2
Unspecified Adult Solid Tumor, Protocol Specific
1
Thyroid Neoplasms
1
Stomatitis
1
Stomach Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Smoking Cessation
1
Skin Neoplasms
1
Shoulder Pain
1
Respiration Disorders
1
Psychological Well-Being
1
Postoperative Complications
1
Post-thoracotomy Pain Syndrome
1
Pleural Diseases
1
Neoplasms
1
Mouth Neoplasms
1
Interventions
Cisplatin
168
Radiotherapy
110
pembrolizumab
96
Cetuximab
95
Docetaxel
74
Carboplatin
74
Radiotherapy, Intensity-Modulated
55
Paclitaxel
51
Nivolumab
50
Fluorouracil
47
Surgical Procedures, Operative
28
Radiation
26
Magnetic Resonance Spectroscopy
25
durvalumab
23
Drug Therapy
23
Radiosurgery
21
Biopsy
19
Albumin-Bound Paclitaxel
19
130-nm albumin-bound paclitaxel
18
Taxes
17
tislelizumab
16
toripalimab
15
Chemoradiotherapy
15
Neoadjuvant Therapy
14
Erlotinib Hydrochloride
14
Blood Specimen Collection
14
camrelizumab
13
Immunohistochemistry
13
Specimen Handling
12
tremelimumab
11
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Squamous Cell Carcinoma of Head and Neck
×
Tea
×
Clear all
NCT06875791
2025-04-01
TEMOR
Fundacion Clinica Valle del Lili
Phase 1/2
Not yet recruiting
40 enrolled